Bristol Myers Squibb (BMY) Debt Ratio (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Debt Ratio for 18 consecutive years, with 0.5 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Debt Ratio fell 11.64% year-over-year to 0.5 in Q2 2026; TTM through Jun 2026 was 0.5, a 11.64% decrease from a year earlier, with the FY2025 full-year figure at 0.52, down 5.92% from the prior year.
• Debt Ratio was 0.5 for Q2 2026 at Bristol Myers Squibb, down from 0.54 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.59 in Q1 2024 and troughed at 0.42 in Q3 2022.
• A 5-year average of 0.51 and a median of 0.52 in 2022 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio declined 16.19% in 2023 and soared 39.06% in 2024, its largest moves.
• Over 5 years, Debt Ratio stood at 0.45 in 2022, then advanced by 0.4% to 0.45 in 2023, then advanced by 24.04% to 0.56 in 2024, then declined by 5.92% to 0.52 in 2025, then retreated by 4.24% to 0.5 in 2026.
• The last three Debt Ratio figures came in at 0.5 (Q2 2026), 0.54 (Q1 2026), and 0.52 (Q4 2025), per Business Quant data.